owensilcox, Author at European Medical Journal

Navigating comorbidities and polypharmacy in mHSPC

This video podcast covers the current treatment landscape for mHSPC and covers the burden of comorbidities and polypharmacy. Our experts…

Retraction: Sponsored Content: Optimising ▼Enfortumab Vedotin + Pembrolizumab in Comorbid Patients with Unresectable or Metastatic Urothelial Carcinoma

30 Apr 2026

Managing Adverse Events in HR+/HER2– Advanced Breast Cancer

Explore practical recommendations built to support patient counseling, monitoring, triage, management, and safe re-initiation…

EMJ's latest Urology Journal

Urology is moving fast. The clinicians driving that change don’t wait to catch up—they lead.Get the clinical intelligence required to…

EMJ's latest Radiology Journal

Radiology’s biggest shift in a generation is already underway – and the healthcare professionals leading that change are reading our…

The Importance of BRAF Testing in NSCLC

BRAF mutations are rare, occurring in around 2-4% of patients with NSCLC. Around 50% of BRAF mutations are BRAFV60 mutations, which mostly…

Alzheimer's disease: Insights into disease progression and biomarkers

Video 1 explores the evolving understanding of Alzheimer’s disease (AD) as an amyloid-driven tauopathy, while video 2 delves into the role…

10 Apr 2026

Exploring Hidden Gaps in Asthma Biologic Adherence

Explore unmet needs in asthma biologics, focusing on adherence, risk factors, and outcomes in this interactive infographic.

10 Apr 2026

Managing an Itchy Rash in an Infant

This interactive case study was organised and funded by Viatris. A 4-month-old female infant presented with itching and red skin patches…

What’s New in Targeted Therapy for Chronic Inflammatory Skin Disease?

Catch up on selected 2025-2026 conference data across AD, CHE, GPP, and PG, including symptom burden, long-term disease impact, and…